Private Market View

Angpu Bio

Shanghai, China · Founded 2013 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Prosperico Ventures, Beijing Jinhuifeng Investment Management, Ltd., Taizhou Huacheng Medical Investment Group Co., Vista Up Capital.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 5 names
  • ·Watchlist + deal alerts for Angpu Bio
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Angpu Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Angpu Bio

Manufacturer of medical equipment intended for healthcare applications. The company offers precision engineering, durable materials, ergonomic design, compliance with regulatory standards, and adaptable configurations, enabling healthcare providers to improve patient outcomes, streamline clinical workflows, enhance safety in medical procedures, reduce operational inefficiencies, and support a wide range of diagnostic and therapeutic practices across diverse medical environments.

Sector
Healthcare
HQ
Shanghai, China
Founded
2013
Ownership
Privately Held (backing)
PA Mark — not yet priced

Angpu Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Angpu Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Angpu Bio in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.